KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Operating Expenses (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Operating Expenses readings, the most recent being $526.0 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 3.31% to $526.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.3 billion, a 4.54% increase, with the full-year FY2025 number at $2.3 billion, up 6.53% from a year prior.
  • Operating Expenses hit $526.0 million in Q1 2026 for Teva Pharmaceutical Industries, down from $634.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $634.0 million in Q4 2025 to a low of $458.0 million in Q3 2022.
  • Median Operating Expenses over the past 5 years was $538.0 million (2024), compared with a mean of $536.5 million.
  • Biggest five-year swings in Operating Expenses: dropped 10.72% in 2022 and later grew 15.48% in 2025.
  • Teva Pharmaceutical Industries' Operating Expenses stood at $498.0 million in 2022, then grew by 4.22% to $519.0 million in 2023, then increased by 5.78% to $549.0 million in 2024, then increased by 15.48% to $634.0 million in 2025, then fell by 17.03% to $526.0 million in 2026.
  • The last three reported values for Operating Expenses were $526.0 million (Q1 2026), $634.0 million (Q4 2025), and $573.0 million (Q3 2025) per Business Quant data.